Liu LL - Search Results

1

A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients.

Xiong SP, Wang CH, Zhang MF, Yang X, Yun JP, Liu LL. Xiong SP, et al. Among authors: liu ll. J Transl Med. 2024 May 18;22(1):472. doi: 10.1186/s12967-024-05296-3. J Transl Med. 2024. PMID: 38762511 Free PMC article.

2

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis.

Huang Y, Li LZ, Zhang CZ, Yi C, Liu LL, Zhou X, Xie GB, Cai MY, Li Y, Yun JP. Huang Y, et al. Among authors: liu ll. J Transl Med. 2012 May 24;10:106. doi: 10.1186/1479-5876-10-106. J Transl Med. 2012. PMID: 22625427 Free PMC article.

3

Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo.

Zhang CZ, Pan Y, Cao Y, Lai PB, Liu L, Chen GG, Yun J. Zhang CZ, et al. PLoS One. 2012;7(6):e39870. doi: 10.1371/journal.pone.0039870. Epub 2012 Jun 28. PLoS One. 2012. PMID: 22761917 Free PMC article.

4

Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.

Liu L, Zhang CZ, Cai M, Fu J, Chen GG, Yun J. Liu L, et al. PLoS One. 2012;7(7):e41293. doi: 10.1371/journal.pone.0041293. Epub 2012 Jul 19. PLoS One. 2012. PMID: 22829937 Free PMC article.

5

Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.

Zhang CZ, Liu L, Cai M, Pan Y, Fu J, Cao Y, Yun J. Zhang CZ, et al. PLoS One. 2012;7(12):e51703. doi: 10.1371/journal.pone.0051703. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23272146 Free PMC article.

6

Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis.

Fu J, Qiu H, Cai M, Pan Y, Cao Y, Liu L, Yun J, Zhang CZ. Fu J, et al. Cancer Sci. 2013 Apr;104(4):508-15. doi: 10.1111/cas.12100. Epub 2013 Feb 17. Cancer Sci. 2013. PMID: 23305207 Free PMC article.

7

Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.

Luo R, Zhang M, Liu L, Lu S, Zhang CZ, Yun J. Luo R, et al. PLoS One. 2013 Aug 1;8(8):e70511. doi: 10.1371/journal.pone.0070511. Print 2013. PLoS One. 2013. PMID: 23936443 Free PMC article.

8

miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou X, Zhang ZJ, Peng YH, Yang YZ, Yun JP. Li LZ, et al. Among authors: liu ll. Carcinogenesis. 2014 Feb;35(2):469-78. doi: 10.1093/carcin/bgt330. Epub 2013 Oct 1. Carcinogenesis. 2014. PMID: 24085799

9

NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis.

Liu LL, Zhang MF, Pan YH, Yun JP, Zhang CZ. Liu LL, et al. Tumour Biol. 2014 Mar;35(3):1763-74. doi: 10.1007/s13277-013-1184-2. Epub 2014 Feb 25. Tumour Biol. 2014. PMID: 24563371

10

FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.

Liu LL, Lu SX, Li M, Li LZ, Fu J, Hu W, Yang YZ, Luo RZ, Zhang CZ, Yun JP. Liu LL, et al. Oncotarget. 2014 Jul 15;5(13):5113-24. doi: 10.18632/oncotarget.2089. Oncotarget. 2014. PMID: 24970808 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,280 results

Search Page

Filters